Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biote (BTMD) Cash & Current Investments (2021 - 2025)

Biote (BTMD) has 5 years of Cash & Current Investments data on record, last reported at $28.0 million in Q3 2025.

  • For Q3 2025, Cash & Current Investments fell 26.62% year-over-year to $28.0 million; the TTM value through Sep 2025 reached $28.0 million, down 26.62%, while the annual FY2024 figure was $39.3 million, 55.8% down from the prior year.
  • Cash & Current Investments reached $28.0 million in Q3 2025 per BTMD's latest filing, up from $19.6 million in the prior quarter.
  • Across five years, Cash & Current Investments topped out at $89.0 million in Q4 2023 and bottomed at $19.6 million in Q2 2025.
  • Average Cash & Current Investments over 5 years is $53.5 million, with a median of $40.5 million recorded in 2024.
  • Peak YoY movement for Cash & Current Investments: surged 265.57% in 2022, then plummeted 70.14% in 2024.
  • A 5-year view of Cash & Current Investments shows it stood at $26.8 million in 2021, then soared by 196.01% to $79.2 million in 2022, then rose by 12.33% to $89.0 million in 2023, then plummeted by 55.8% to $39.3 million in 2024, then dropped by 28.71% to $28.0 million in 2025.
  • Per Business Quant database, its latest 3 readings for Cash & Current Investments were $28.0 million in Q3 2025, $19.6 million in Q2 2025, and $41.7 million in Q1 2025.